France Archives

News and Trends 3 Jun 2015

Avantium’s bioplastic, latest Green Hope for the Agribusiness?

After many awards and famous collaborations, the Dutch biotech company Avantium signed a deal with Tereos for the production of its 100% biobased plastic. The Bioplastic provider is moving forward to disrupt an established market! Initially created as a spin off of Shell, Avantium is a 15 years old Dutch company specialized in the area of advanced […]

June 3, 2015 - 2 minutesmins - By Joachim Eeckhout

News and Trends 2 Jun 2015

Genticel aims to prevent Cancer caused by the Human Papillomavirus

Genticel is a step closer to prevent cancer caused by the human papillomavirus (HPV). The French biotech announced positive results of GTL002’s preclinical in vivo proof of concept, Genticel’s multivalent HPV therapeutic vaccine candidate based on the company’s versatile Vaxiclase platform. Vaxiclase is a technology platform that can be used with many antigens in several […]

June 2, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 2 Jun 2015

Will Glowee Replace Electric Lighting with Bioluminescent Bacteria?

What if we could use less electricity to light today’s civilizations? Glowee is a French start-up willing to take on this challenge by using genetically modified bacteria to produce light. I had the chance to talk with the company’s CEO Sandra Rey and will give you my thoughts. It all started from a student project in a design college. Back […]

June 2, 2015 - 3 minutesmins - By Philip Hemme

News and Trends 1 Jun 2015

DNA Therapeutics presents positive results for its breakthrough Advanced Cancer Therapy

ASCO Annual Meeting keeps bringing positive results of European companies that cross the ocean to present their clinical trial outcomes. DNA Therapeutics, the French biopharma, presented the results of the first-in-man phase I/IIa trial of DT01 in patients with cutaneous metastatic melanoma. Cancer cells can easily repair themselves after damage incurred in their DNA from […]

June 1, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 31 May 2015

Who are the European Cancer Champions?

Cancer makes no difference… Children, elderly, healthy, disabled, black, white, etc… the disease randomly selects its targets. One of the biggest challenges of the Biotech industry today, is to lead groundbreaking innovations capable of treating cancer, which also encompass each individual’s biological specificity. So who are the leading champions? Recently, Thomson Reuters listed the 5 […]

May 31, 2015 - 2 minutesmins - By Alexandre Lowrey

News and Trends 29 May 2015

Pfizer to Control Cellectis in a €1.5 Billion Deal?

Rumors are saying that French Cellectis is in talks about its potential sale. US-giant Pfizer is considered to be among the buyers. According to The Financial Time, two people familiar with the situation said Cellectis was in negotiations over a deal, but warned no outcome was certain. The Financial Time also declared that “one person […]

May 29, 2015 - 2 minutesmins - By Joachim Eeckhout

News and Trends 29 May 2015

Poxel is Looking towards Japan’s Lucrative Diabetes Market

Poxel, the French company that made a €27M IPO last February, announced the successful conclusion of a phase 1 clinical trial in Japanese subjects with Imeglimin, its lead drug candidate. Imeglimin has already completed phase 2 clinical trials in type 2 diabetes patients in the US and EU and is ready for Phase III. This […]

May 29, 2015 - 2 minutesmins - By Joachim Eeckhout

News and Trends 28 May 2015

Biotechs outperformed in the top 40 European Tech Companies

EnterNext, the Euronext subsidiary dedicated to promoting and growing the market for SMEs (Small and Medium-size companies), announced the launch of Tech 40, a label recognizing innovative European SMEs. Tech 40 puts young tech companies listed on Euronext markets – in Amsterdam, Brussels, Lisbon or Paris – under the spotlight. Companies awarded with the Tech 40 are operating in […]

May 28, 2015 - 2 minutesmins - By Nicolas Sainte-Foie

News and Trends 28 May 2015

Deinove Reaches Critical Milestones and Gets Recognition in the US

May 2015 is a great month for Deinove! The French company focused on Deinococci bacteria for green chemistry. Deinove reached critical milestone achievements in its industrial collaboration with Avril and their scientists gained major recognition in the US. Deinove is definitely on the front of the stage! A few days ago, Emmanuel Petiot, CEO of Deinove, declared that “All Deinove teams are […]

May 28, 2015 - 2 minutesmins - By Joachim Eeckhout

News and Trends 26 May 2015

L’Oreal is Bioprinting Human Skin to Stop Animal Testing

A huge improvement could shake the cosmetic testing field very soon. L’Oreal, the French world leader in beauty cosmetics, mostly known for its make-up and hair care products, has just started a partnership with Organovo to print human skin. The amazing thing here is that L’Oreal has already been thinking about giving priority to human skin tests […]

May 26, 2015 - 3 minutesmins - By Julie Lellouche

News and Trends 25 May 2015

Invectys focuses on Telomers to develop a Universal Cancer Vaccine

French startup Invectys believes to have found the solution to cancer: one vaccine to cure them all! By targeting telomerase, this new immunotherapy could theoretically fight 95 % of all human cancers. When a cell divides, a small piece of DNA, called telomere, is lost at both ends of each chromosome. Telomerase adds these pieces of DNA again at the end of […]

May 25, 2015 - 3 minutesmins - By Joachim Eeckhout

News and Trends 22 May 2015

Fluorescent antibodies to guide Cancer surgery

French oncologist SurgiMab has started a first-in-human phase I study for its molecule SGM-101 launched at the Montpellier Cancer Institute. SurgiMab is developing antibody-fluorochrome conjugates to be used as in vivo diagnostic agents in oncology. SGM-101 is a fluorescent conjugate that consists on a tumor-specific monoclonal antibody and a near-infrared emitting fluorochrome. Thanks to this conjugate, oncology surgeons will […]

May 22, 2015 - 1 minutemin - By Lourdes Riquelme

Resources

Categories

The twelve hottest biotech companies in the Boston area

Biotech bankruptcies: what to expect in 2024 following a record year?

Approaches

Therapeutic areas

RNA editing set to take off: could it outperform gene editing?

Future of cancer treatment: what will therapy look like in 2034?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us